Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00006656 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Direct Therapeutics